Cargando…
Nanomedicine in the Management of Alzheimer’s Disease: State-of-the-Art
Alzheimer’s disease (AD) is a deadly, progressive, and irreversible brain condition that impairs cognitive abilities. Globally, it affects 32.6 million individuals, and if no viable therapies are available by 2050, that figure might rise to 139 million. The current course of treatment enhances cogni...
Autores principales: | Mir Najib Ullah, Shehla Nasar, Afzal, Obaid, Altamimi, Abdulmalik Saleh Alfawaz, Ather, Hissana, Sultana, Shaheen, Almalki, Waleed H., Bharti, Pragya, Sahoo, Ankit, Dwivedi, Khusbu, Khan, Gyas, Sultana, Shahnaz, Alzahrani, Abdulaziz, Rahman, Mahfoozur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296528/ https://www.ncbi.nlm.nih.gov/pubmed/37371847 http://dx.doi.org/10.3390/biomedicines11061752 |
Ejemplares similares
-
Emergence of Nano-Based Formulations for Effective Delivery of Flavonoids against Topical Infectious Disorders
por: Dwivedi, Khusbu, et al.
Publicado: (2023) -
Bedaquiline-Loaded Solid Lipid Nanoparticles Drug Delivery in the Management of Non-Small-Cell Lung Cancer (NSCLC)
por: Najib Ullah, Shehla Nasar Mir, et al.
Publicado: (2023) -
Preparation, Characterization,
and Evaluation of Curcumin–Graphene
Oxide Complex-Loaded Liposomes against Staphylococcus aureus in Topical Disease
por: Rahman, Mahfoozur, et al.
Publicado: (2022) -
Superficial Dermatophytosis
across the World’s
Populations: Potential Benefits from Nanocarrier-Based Therapies and
Rising Challenges
por: Keshwania, Puja, et al.
Publicado: (2023) -
Cationic Solid Lipid Nanoparticles of Resveratrol for Hepatocellular Carcinoma Treatment: Systematic Optimization, in vitro Characterization and Preclinical Investigation
por: Rahman, Mahfoozur, et al.
Publicado: (2020)